Increased mTOR activation in idiopathic multicentric Castleman disease

被引：0
|
作者：
Arenas, Daniel [1 ]
Floess, Katherine [1 ]
Kobrin, Dale [1 ]
Srkalovic, Maya [1 ]
Pierson, Sheila [1 ]
Martinez, Daniel [2 ]
Fajgenbaum, David [3 ]
机构：
[1] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Castleman disease;
D O I：
10.1016/j.clml.2019.09.502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-176
引用
收藏
页码：E306 / E306
页数：1
相关论文
共 50 条
  • [1] Increased mTOR activation in idiopathic multicentric Castleman disease
    Arenas, Daniel J.
    Floess, Katherine
    Kobrin, Dale
    Pai, Ruth-Anne Langan
    Srkalovic, Maya B.
    Tamakloe, Mark-Avery
    Rasheed, Rozena
    Ziglar, Jasira
    Khor, Johnson
    Parente, Sophia A. T.
    Pierson, Sheila K.
    Martinez, Daniel
    Wertheim, Gerald B.
    Kambayashi, Taku
    Baur, Joseph
    Teachey, David T.
    Fajgenbaum, David C.
    BLOOD, 2020, 135 (19) : 1673 - 1684
  • [2] A Type I interferon response is associated with increased mTOR activation in idiopathic multicentric Castleman disease
    Pai, Ruth-Anne Langan
    Japp, Alberto Sada
    Gonzalez, Michael
    Rasheed, Rozena F.
    Okumura, Mariko
    Arenas, Daniel
    Pierson, Sheila K.
    Layman, Awo Akosua Kesewa
    Kao, Charlly
    Hakonarson, Hakon
    van Rhee, Frits
    Betts, Michael R.
    Kambayashi, Taku
    Fajgenbaum, David C.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [3] Targeting the mTOR pathway in idiopathic multicentric Castleman disease
    Stern, Robert M.
    Berliner, Nancy
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (10): : 4086 - 4088
  • [4] Increased Comorbidities and Hospitalizations Associated with Idiopathic Multicentric Castleman Disease
    Bustamante, Mateo Sarmiento
    Pierson, Sheila K.
    Ren, Yue
    Alapat, Daisy
    Bagg, Adam
    Brandstadter, Joshua D.
    Lechowicz, Mary Jo
    Lee, Hongzhe
    Srkalovic, Gordan
    Lim, Megan S.
    van Rhee, Frits
    Fajgenbaum, David C.
    BLOOD, 2022, 140 : 6520 - 6521
  • [5] Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease
    Pai, Ruth-Anne Langan
    Japp, Alberto Sada
    Gonzalez, Michael
    Rasheed, Rozena F.
    Okumura, Mariko
    Arenas, Daniel
    Pierson, Sheila K.
    Powers, Victoria
    Layman, Awo Akosua Kesewa
    Kao, Charlly
    Hakonarson, Hakon
    van Rhee, Frits
    Betts, Michael R.
    Kambayashi, Taku
    Fajgenbaum, David C.
    JCI INSIGHT, 2020, 5 (09)
  • [6] Idiopathic multicentric Castleman disease
    Chaudhari, Vipul
    Thakkar, Simran Jatin
    Padwal, Namita
    Karnik, Niteen
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (05) : 1602 - 1604
  • [7] Idiopathic multicentric Castleman's disease
    Vasilyev, V., I
    Palshina, S. G.
    Pavlovskaya, A., I
    Kokosadze, N., V
    Chaltsev, B. D.
    Shornikova, L. A.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (05) : 78 - +
  • [8] Dissecting idiopathic multicentric Castleman's disease
    Dupin, Nicolas
    LANCET HAEMATOLOGY, 2016, 3 (04): : E153 - E154
  • [9] Polynesian Variant Of Idiopathic Multicentric Castleman Disease
    Zhai, Shaun
    Simpson, David
    BLOOD, 2013, 122 (21)
  • [10] Idiopathic multicentric Castleman disease of TAFRO subtype
    Godfrey, Katherine
    Harris, Emma
    Moss, Hilary
    Martin-Cabrera, Pedro
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 461 - 461
12345